Member Login

Username:       Password:

 Remember me Lost your password?

Not a member yet? Sign Up!

Organization:
Email:

I agree to the terms and conditions
Search
Refine
  • Associated Entities
  • Broad Categories
  • Journals
  • Author
  • View All






Webinar



Understanding multiple target preferences for Drug Re - purposing & therapeutic Switching in Cancer Therapies


more....







The only Semantic discovery and Expert annotated Knowledgebase platform updated with "manually" annotated facts from PubMed on a regular basis.


Access Now







XTractor Alerts enables in managing searches and storing the most significant information tagged in a personalized profile.


Access Now




Help X
  • Protein
  • Disease
  • Drug
  • Process
? x
Journals



Author



Affiliation



Publications



Associated Entities



Symbol:
Caffeine
Alias:
Caffeine; Alert-Pep; Anoquan; CFF; Cafamil; Cafcit; Cafecon; Cafeina; Cafergot; Caffedrine; Caffedrine Caplets; Caffein; Caffeine Pure; Caffeine, Anhydrous; Caffeine, Monohydrate; Caffeine, Synthetic; Caffine; Cafipel; Coffein; Coffeine; Compound 65; Darvon Compound; Darvon Compound-65; Dasin; Dexitac; Dexitac Stay Alert Stimulant; Dhc Plus; Diurex; Durvitan; Eldiatric C; Enerjets; Ercatab; Esgic; Esgic-Plus; Femcet; Fioricet; Fiorinal; Guaranine; Hycomine; Invagesic; Invagesic Forte; Keep Alert; Kofein; Koffein; Lanorinal; Mateina; Maximum Strength Snapback Stimulant Powders; Medigesic Plus; Methyltheobromide; Methyltheobromine; Migergot; Miudol; Monomethyl Derivative of Theophylline; Natural Caffeinum; Nix Nap; No-Doz; Nodaca; Nodoz Maximum Strength Caplets; Norgesic; Norgesic Forte; Organex; Orphengesic; Orphengesic Forte; Pep-Back; Phensal; Propoxyphene Compound 65; Propoxyphene Compound-65; Quick Pep; Refresh'n; SK 65 Compound; Stim; Synalgos-Dc; Thein; Theine; Theobromine ME; Theophylline ME; Triad; Ultra Pep-Back; Vivarin; Wake-Up; Wigraine

Result For Caffeine

Total References : 17642
  • Year: 
  •  
References for year 2010: 157
  • 10
  • 20
  • 50
Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells.
PMID:20041972
Author: Germanguz I, Sedan O, Zeevi-Levin N, Shtreichman R, Barak E, Ziskind A, Eliyahu S, Meiry G, Amit M, Itskovitz-Eldor J, Binah O
Journal: J Cell Mol Med
Affiliation: The Sohnis Family Stem Cells Center, Technion - Israel Institute of Technology, Haifa, Israel.
Abstract In view of the therapeutic potential of cardiomyocytes derived from induced pluripotent stem (iPS) cells (iPS-derived cardiomyocytes), in the present study we investigated in iPS-derived cardiomyocytes, the functional properties related to [Ca(2+)](i) handling and contraction, the contribution of the sarcoplasmic reticulum Ca(2+) release to contraction and the beta-adrenergic inotropic responsiveness. The two iPS clones investigated here were generated through infection of human foreskin fibroblasts (HFF) with retroviruses containing the four human genes: OCT4, Sox2, Klf4 and C-Myc. more...
Abstract In view of the therapeutic potential of cardiomyocytes derived from induced pluripotent stem (iPS) cells (iPS-derived cardiomyocytes), in the present study we investigated in iPS-derived cardiomyocytes, the functional properties related to [Ca(2+)](i) handling and contraction, the contribution of the sarcoplasmic reticulum Ca(2+) release to contraction and the beta-adrenergic inotropic responsiveness. The two iPS clones investigated here were generated through infection of human foreskin fibroblasts (HFF) with retroviruses containing the four human genes: OCT4, Sox2, Klf4 and C-Myc. Our major findings showed that iPS-derived cardiomyocytes: (1) express cardiac specific RNA and proteins; (2) exhibit negative force-frequency relations and mild (compared to adult) post-rest potentiation; (3) respond to ryanodine and caffeine, albeit less than adult cardiomyocytes, and express the SR-Ca(2+) handling proteins ryanodine receptor and calsequestrin. Hence, this study demonstrates that in our cardiomyocytes clones differentiated from human foreskin fibroblasts-derived iPS, the functional properties related to excitation-contraction coupling, resemble in part those of adult cardiomyocytes. less...
GeneDiseaseDrugProcessesCategories
  • MYC_HUMAN
  • PO5F1_HUMAN
  • SOX2_HUMAN
  • KLF4_HUMAN
  • Caffeine
  • Protein/Gene relationships
The two iPS clones investigated here were generated through infection of human foreskin fibroblasts (HFF) with retroviruses containing the four human genes: OCT4, Sox2, Klf4 and C-Myc.
GeneDiseaseDrugProcessesCategories
  • MYC_HUMAN
  • PO5F1_HUMAN
  • SOX2_HUMAN
  • KLF4_HUMAN
  • Protein/Gene relationships

Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study.
PMID:20042259
Author: Jamal SA, Swan VJ, Brown JP, Hanley DA, Prior JC, Papaioannou A, Langsetmo L, Josse RG
Journal: Am J Kidney Dis
Affiliation: University of Toronto.
BACKGROUND: The relationship between kidney function and bone loss is unclear. STUDY DESIGN: A prospective observational study. more...
BACKGROUND: The relationship between kidney function and bone loss is unclear. STUDY DESIGN: A prospective observational study. SETTING & PARTICIPANTS: 191 men and 444 women aged >/= 50 years participating in a population-based observational study designed to determine risk factors for bone loss and fractures. PREDICTORS: The primary predictor of change in bone mineral density (BMD) was estimated creatinine clearance (using the Cockcroft-Gault formula) measured at baseline and stratified by quartiles. Our secondary predictor was estimated glomerular filtration rate using the Modification of Diet in Renal Disease Study equation, also stratified by quartiles. OUTCOMES & MEASUREMENTS: Changes in BMD at the lumbar spine, total hip, and femoral neck during 5 years. RESULTS: Compared with participants in the first quartile of estimated creatinine clearance (>101.2 mL/min), those in remaining quartiles were older (quartile 1, 50.0 years; quartile 2 [101.2-83.4 mL/min], 54.7 years; quartile 3 [83.4-68.3 mL/min], 60.5 years; and quartile 4 [<68.3 mL/min], 68.3 years); weighed less; reported more sedentary hours; were less likely to report excellent, very good, or good self-reported health; consumed less caffeine; and had lower serum calcium and phosphate and higher serum parathyroid hormone levels. After adjusting for age, weight, sex, baseline BMD, and these differences, compared with those in the first quartile, those in the fourth quartile had decreases in BMD of 0.08 g/cm(2) (95% CI, 0.04-0.1) at the lumbar spine, 0.08 g/cm(2) (95% CI, 0.06-0.1) at the femoral neck, and 0.09 g/cm(2) (95% CI, 0.07-0.1) at the total hip. Bone loss did not increase with worsening kidney function (P for trend > 0.05). Results were not substantially different using estimated glomerular filtration rate. LIMITATIONS: Observational study design and indirect measures of kidney function. CONCLUSIONS: Men and women with impaired kidney function are at increased risk of bone loss, even with minimal reduction in kidney function. less...
GeneDiseaseDrugProcessesCategories
  • PTHY_HUMAN
  • Osteoporosis
  • Caffeine
  • glomerular filtration
  • Protein/Gene relationships
RESULTS: Compared with participants in the first quartile of estimated creatinine clearance (>101.2 mL/min), those in remaining quartiles were older (quartile 1, 50.0 years; quartile 2 [101.2-83.4 mL/min], 54.7 years; quartile 3 [83.4-68.3 mL/min], 60.5 years; and quartile 4 [<68.3 mL/min], 68.3 years); weighed less; reported more sedentary hours; were less likely to report excellent, very good, or good self-reported health; consumed less caffeine; and had lower serum calcium and phosphate and higher serum parathyroid hormone levels.
GeneDiseaseDrugProcessesCategories
  • PTHY_HUMAN
  • Caffeine
  • Protein/Gene relationships

Genomic analysis of severe hypersensitivity to hygromycin B reveals linkage to vacuolar defects and new vacuolar gene functions in Saccharomyces cerevisiae
PMID:20043226
Author: Banuelos MG, Moreno DE, Olson DK, Nguyen Q, Ricarte F, Aguilera-Sandoval CR, Gharakhanian E
Journal: Curr Genet
Affiliation: Department of Biological Sciences, California State University at Long Beach, 1250 Bellflower Blvd, Long Beach, CA, 90840, USA.
The vacuole of Saccharomyces cerevisiae has been a seminal model for studies of lysosomal trafficking, biogenesis, and function. Several yeast mutants defective in such vacuolar events have been unable to grow at low levels of hygromycin B, an aminoglycoside antibiotic. more...
The vacuole of Saccharomyces cerevisiae has been a seminal model for studies of lysosomal trafficking, biogenesis, and function. Several yeast mutants defective in such vacuolar events have been unable to grow at low levels of hygromycin B, an aminoglycoside antibiotic. We hypothesized that such severe hypersensitivity to hygromycin B (hhy) is linked to vacuolar defects and performed a genomic screen for the phenotype using a haploid deletion strain library of non-essential genes Fourteen HHY genes were initially identified and were subjected to bioinformatics analyses. The uncovered hhy mutants were experimentally characterized with respect to vesicular trafficking, vacuole morphology, and growth under various stress and drug conditions. The combination of bioinformatics analyses and phenotypic characterizations implicate defects in vesicular trafficking, vacuole fusion/fission, or vacuole function in all hhy mutants. The collection was enriched for sensitivity to monensin, indicative of vacuolar trafficking defects. Additionally, all hhy mutants showed severe sensitivities to rapamycin and caffeine, suggestive of TOR kinase pathway defects. Our experimental results also establish a new role in vacuolar and vesicular functions for two genes: PAF1, encoding a RNAP II-associated protein required for expression of cell cycle-regulated genes, and TPD3, encoding the regulatory subunit of protein phosphatase 2A. Thus, our results support linkage between severe hypersensitivity to hygromycin B and vacuolar defects less...
GeneDiseaseDrugProcessesCategories
  • PP2AB_HUMAN
  • Hypersensitivity
  • Caffeine
  • Sirolimus
  • hypersensitivity
  • cell cycle

Drug metabolizing enzyme CYP1A2 status in pediatric patients with hemoglobin E-beta thalassemia.
PMID:20043572
Author: Senggunprai L, Kukongviriyapan U, Jetsrisuparb A, Kukongviriyapan V
Journal: J Med Assoc Thai
Affiliation: Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
OBJECTIVE: To evaluate the drug metabolizing enzyme CYP1A2 activity in pediatric hemoglobin E-beta-thalassemia patients, since CYP1A2 is responsible for the metabolism of a number of drugs. Alteration of its activity may have clinical consequences. more...
OBJECTIVE: To evaluate the drug metabolizing enzyme CYP1A2 activity in pediatric hemoglobin E-beta-thalassemia patients, since CYP1A2 is responsible for the metabolism of a number of drugs. Alteration of its activity may have clinical consequences. MATERIAL AND METHOD: Twenty-three hemoglobin E-beta thalassemia pediatric patients and 24 age-matched controls were recruited in the present study. Caffeine in the form of a soft drink was orally administered as a test probe for CYP1A2 activity. Plasma collected at pre-dose and 6 hr after intake was analyzed for the levels of caffeine and paraxanthine, its major metabolite to represent the activity of CYPIA2. RESULTS: Biochemical markers, including blood glutathione and urinary lipid hydroperoxides indicated that patients were in an oxidant stress state. The plasma ratio ofparaxanthine to caffeine was unchanged between patients and controls. Multiple regression analysis revealed that gender and the liver enzyme were the significant determinants of CYP1A2 activity (adjusted r2 = 0.48, p < 0.001). Male gender was associated with higher activity of CYP1A2 activity. CONCLUSION: The CYP1A2 activity is not apparently changed in thalassemia patients despite the presence of an oxidative stress state. less...
GeneDiseaseDrugProcessesCategories
  • CP1A2_HUMAN
  • Thalassemia
  • Caffeine
  • Protein/Gene relationships
Drug metabolizing enzyme CYP1A2 status in pediatric patients with hemoglobin E-beta thalassemia.
GeneDiseaseDrugProcessesCategories
  • CP1A2_HUMAN
  • Thalassemia
  • Protein/Gene relationships
Caffeine in the form of a soft drink was orally administered as a test probe for CYP1A2 activity.
GeneDiseaseDrugProcessesCategories
  • CP1A2_HUMAN
  • Caffeine
  • Protein/Gene relationships
Plasma collected at pre-dose and 6 hr after intake was analyzed for the levels of caffeine and paraxanthine, its major metabolite to represent the activity of CYPIA2.
GeneDiseaseDrugProcessesCategories
  • CP1A2_HUMAN
  • Caffeine
  • Protein/Gene relationships
CONCLUSION: The CYP1A2 activity is not apparently changed in thalassemia patients despite the presence of an oxidative stress state.
GeneDiseaseDrugProcessesCategories
  • CP1A2_HUMAN
  • Thalassemia
  • Protein/Gene relationships

Efficiency of the same neat silica column in hydrophilic interaction chromatography and per aqueous liquid chromatography.
PMID:20044093
Author: Gritti F, Dos Santos Pereira A, Sandra P, Guiochon G
Journal: J Chromatogr A
Affiliation: Department of Chemistry, University of Tennessee, Knoxville, TN 37996-1600, USA.
The dependencies on the mobile phase flow velocity of the efficiency of a column packed with shell particles of neat porous silica (Halo) was measured under two different sets of experimental conditions. These conditions corresponded to the retention mechanisms of per aqueous liquid chromatography (PALC) at low acetonitrile concentrations and of hydrophilic interaction chromatography (HILIC) at high acetonitrile concentrations. more...
The dependencies on the mobile phase flow velocity of the efficiency of a column packed with shell particles of neat porous silica (Halo) was measured under two different sets of experimental conditions. These conditions corresponded to the retention mechanisms of per aqueous liquid chromatography (PALC) at low acetonitrile concentrations and of hydrophilic interaction chromatography (HILIC) at high acetonitrile concentrations. The results are compared. Small amounts of a diluted solution of caffeine were injected in order to record the chromatograms under strictly linear conditions. These efficiencies were measured in both water-rich (PALC retention mechanism) and acetonitrile-rich (HILIC mechanism) mobile phases for the same retention factors, between 0.25 and 2.5. The mobile phases were mixtures of acetonitrile and water containing neither supporting salt nor buffer component. At low retention factors, the efficiency of caffeine is better in the PALC than in the HILIC mode. For k(')=0.5, the minimum reduced height equivalent to a theoretical plate (HETP) is close to 2.5 in PALC while it exceeds 5 in HILIC. The converse is true for high retention factors. For k(')>2.5, the HETP is lower in HILIC than in PALC, because the major contribution to band broadening and peak tailing in this latter mode originates from the heterogeneous thermodynamics of retention and eventually restricts column performance in PALC. Most interestingly, the reduced HETP measured in HILIC for caffeine never falls below 4. This suggests that the mass transfer of caffeine between the multilayer adsorbed phase (due to the interactions of the strong solvent and the silanol groups) and the acetonitrile-rich bulk eluent is slow. less...
GeneDiseaseDrugProcessesCategories
  • Caffeine

Central role of nitric oxide synthase in AICAR and caffeine induced mitochondrial biogenesis in L6 myocytes.
PMID:20044477
Author: McConell GK, Ng GP, Phillips M, Ruan Z, Macaulay SL, Wadley GD
Journal: J Appl Physiol
Affiliation: The University of Melbourne.
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and caffeine, which activate AMPK and cause sarcoplasmic reticulum calcium release, respectively, have been shown to increase mitochondrial biogenesis in L6 myotubes. Nitric oxide (NO) donors also increase mitochondrial biogenesis. more...
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and caffeine, which activate AMPK and cause sarcoplasmic reticulum calcium release, respectively, have been shown to increase mitochondrial biogenesis in L6 myotubes. Nitric oxide (NO) donors also increase mitochondrial biogenesis. Since neuronal and endothelial NO synthase (NOS) are calcium-dependent and are also phosphorylated by AMPK, we hypothesized that NOS inhibition would attenuate the activation of mitochondrial biogenesis in response to AICAR and caffeine. L6 myotubes were either not treated (control) or were exposed acutely or for 5 hours/day over 5 days to 100muM of N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor); 100muM S-nitroso-N-acetylpenicillamine (SNAP, NO donor) +/- 100muM L-NAME; 2mM AICAR +/- 100muM L-NAME; or 5mM caffeine +/- 100muM L-NAME (n=12/treatment). Acute AICAR administration increased (P<0.05) phospho- (P-)AMPK, but also increased P-CaMK, with resultant chronic increases in peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1alpha (PGC-1alpha), cytochrome oxidase (COX) I and COXIV protein expression compared with control cells. NOS inhibition, which had no effect on AICAR-stimulated P-AMPK, surprisingly increased P-CaMK and attenuated the AICAR induced increases in COXI and COXIV protein. Caffeine administration, which increased P-CaMK without affecting P-AMPK, increased COXI, COXIV, PGC-1alpha and CS activity. NOS inhibition, surprisingly, greatly attenuated the effect of caffeine on P-CaMK and attenuated the increases in COXI and COXIV protein. SNAP increased all markers of mitochondrial biogenesis and it also increased P-AMPK and P-CaMK. In conclusion, AICAR and caffeine increase mitochondrial biogenesis in L6 myotubes, at least in part, via interactions with NOS. Key words: AMPK, calcium, mitochondria, nitric oxide synthase. less...
GeneDiseaseDrugProcessesCategories
  • PRGC1_HUMAN
  • COX41_HUMAN
  • PUR9_HUMAN
  • AAPK2_HUMAN
  • Caffeine
  • Aicar
  • Nitric Oxide
  • Nitroarginine
  • Protein/Gene relationships
  • Drug based Studies
Central role of nitric oxide synthase in AICAR and caffeine induced mitochondrial biogenesis in L6 myocytes.
GeneDiseaseDrugProcessesCategories
  • PUR9_HUMAN
  • Caffeine
  • Aicar
  • Nitric Oxide
  • Protein/Gene relationships
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and caffeine, which activate AMPK and cause sarcoplasmic reticulum calcium release, respectively, have been shown to increase mitochondrial biogenesis in L6 myotubes.
GeneDiseaseDrugProcessesCategories
  • PUR9_HUMAN
  • AAPK2_HUMAN
  • Caffeine
  • Aicar
  • Protein/Gene relationships
Since neuronal and endothelial NO synthase (NOS) are calcium-dependent and are also phosphorylated by AMPK, we hypothesized that NOS inhibition would attenuate the activation of mitochondrial biogenesis in response to AICAR and caffeine.
GeneDiseaseDrugProcessesCategories
  • PUR9_HUMAN
  • AAPK2_HUMAN
  • Caffeine
  • Aicar
  • Protein/Gene relationships
L6 myotubes were either not treated (control) or were exposed acutely or for 5 hours/day over 5 days to 100muM of N(G)-nitro-L-arginine methyl ester (L-NAME, NOS inhibitor); 100muM S-nitroso-N-acetylpenicillamine (SNAP, NO donor) +/- 100muM L-NAME; 2mM AICAR +/- 100muM L-NAME; or 5mM caffeine +/- 100muM L-NAME (n=12/treatment).
GeneDiseaseDrugProcessesCategories
  • Caffeine
  • Aicar
  • Nitroarginine
  • Drug based Studies
Acute AICAR administration increased (P<0.05) phospho- (P-)AMPK, but also increased P-CaMK, with resultant chronic increases in peroxisome proliferator-activated receptor (PPAR)-gamma coactivator-1alpha (PGC-1alpha), cytochrome oxidase (COX) I and COXIV protein expression compared with control cells.
GeneDiseaseDrugProcessesCategories
  • PRGC1_HUMAN
  • COX41_HUMAN
  • PUR9_HUMAN
  • AAPK2_HUMAN
  • Aicar
  • Protein/Gene relationships
NOS inhibition, which had no effect on AICAR-stimulated P-AMPK, surprisingly increased P-CaMK and attenuated the AICAR induced increases in COXI and COXIV protein.
GeneDiseaseDrugProcessesCategories
  • COX41_HUMAN
  • PUR9_HUMAN
  • Aicar
  • Protein/Gene relationships
Caffeine administration, which increased P-CaMK without affecting P-AMPK, increased COXI, COXIV, PGC-1alpha and CS activity.
GeneDiseaseDrugProcessesCategories
  • PRGC1_HUMAN
  • COX41_HUMAN
  • Caffeine
  • Protein/Gene relationships
NOS inhibition, surprisingly, greatly attenuated the effect of caffeine on P-CaMK and attenuated the increases in COXI and COXIV protein.
GeneDiseaseDrugProcessesCategories
  • COX41_HUMAN
  • Caffeine
  • Protein/Gene relationships
In conclusion, AICAR and caffeine increase mitochondrial biogenesis in L6 myotubes, at least in part, via interactions with NOS.
GeneDiseaseDrugProcessesCategories
  • PUR9_HUMAN
  • Caffeine
  • Aicar
  • Protein/Gene relationships
Key words: AMPK, calcium, mitochondria, nitric oxide synthase.
GeneDiseaseDrugProcessesCategories
  • AAPK2_HUMAN
  • Nitric Oxide
  • Protein/Gene relationships

Intracellular Ca2+ Silences L-Type Ca2+ Channels in Mesenteric Veins.Mechanism of Venous Smooth Muscle Resistance to Calcium Channel Blockers.
PMID:20044515
Author: Thakali KM, Kharade SV, Sonkusare SK, Rhee SW, Stimers JR, Rusch NJ
Journal: Circ Res
Affiliation: Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock; and Department of Pharmacology, College of Medicine, University of Vermont, Burlington.
Mechanism of Venous Smooth Muscle Resistance to Calcium Channel Blockers. Rationale: Calcium channel blockers (CCBs) exert their antihypertensive effect by reducing cardiac afterload but not preload, suggesting that Ca(2+) influx through L-type Ca(2+) channels (LTCC) mediates arterial but not venous tone. more...
Mechanism of Venous Smooth Muscle Resistance to Calcium Channel Blockers. Rationale: Calcium channel blockers (CCBs) exert their antihypertensive effect by reducing cardiac afterload but not preload, suggesting that Ca(2+) influx through L-type Ca(2+) channels (LTCC) mediates arterial but not venous tone. Objective: The object of this study was to resolve the mechanism of venous resistance to CCBs. Methods and Results: We compared the sensitivity of depolarization (KCl)-induced constriction of rat small mesenteric arteries (MAs) and veins (MVs) to the dilator effect of CCBs. Initial findings confirmed that nifedipine progressively dilated depolarization-induced constrictions in MAs but not MVs. However, Western blots showed a similar expression of the alpha1C pore-forming subunit of the LTCC in both vessels. Patch-clamp studies revealed a similar density of whole-cell Ca(2+) channel current between single smooth muscle cells (SMCs) of MAs and MVs. Based on these findings, we hypothesized that LTCCs are expressed but "silenced" by intracellular Ca(2+) in venous SMCs. After depletion of intracellular Ca(2+) stores by the SERCA pump inhibitor thapsigargin, depolarization-induced constrictions in MVs were blocked 80% by nifedipine suggesting restoration of Ca(2+) influx through LTCCs. Similarly, KCl-induced constrictions were sensitive to block by nifedipine after depletion of intracellular Ca(2+) stores by caffeine, ryanodine, or 2-aminoethoxydiphenyl borate. Cell-attached patch recordings of unitary LTCC currents confirmed rare channel openings during depolarization of venous compared to arterial SMCs, but chelating intracellular Ca(2+) significantly increased the open-state probability of venous LTCCs. Conclusions: We report that intracellular Ca(2+) inactivates LTCCs in venous SMCs to confer venous resistance to CCB-induced dilation, a fundamental drug property that was previously unexplained. less...
GeneDiseaseDrugProcessesCategories
  • Caffeine

Caffeinol at the Receptor Level.Anti-Ischemic Effect of N-Methyl-D-Aspartate Receptor Blockade Is Potentiated by Caffeine.
PMID:20044532
Author: Zhao X, Strong R, Piriyawat P, Palusinski R, Grotta JC, Aronowski J
Journal: Stroke
Affiliation: From the Stroke Program, Department of Neurology, University of Texas Medical School at Houston.
Anti-Ischemic Effect of N-Methyl-D-Aspartate Receptor Blockade Is Potentiated by Caffeine. BACKGROUND AND PURPOSE: Although caffeinol (a combination of a low dose of caffeine and ethanol) was shown to robustly reduce stroke damage in experimental models and is now in clinical evaluation for treatment of ischemic stroke, little is known about the potential mechanism of its action. more...
Anti-Ischemic Effect of N-Methyl-D-Aspartate Receptor Blockade Is Potentiated by Caffeine. BACKGROUND AND PURPOSE: Although caffeinol (a combination of a low dose of caffeine and ethanol) was shown to robustly reduce stroke damage in experimental models and is now in clinical evaluation for treatment of ischemic stroke, little is known about the potential mechanism of its action. METHODS: We used an in vivo excitotoxicity model based on intracortical infusion of N-methyl-D-aspartate (NMDA) and a model of reversible focal ischemia to demonstrate NMDA receptor inhibition as a potential mechanism of caffeinol anti-ischemic activity. RESULTS: Caffeinol reduced the size of excitotoxic lesion, and substitution of ethanol in caffeinol with the NMDA antagonists CNS-1102 and MK-801 but not with MgSO4 produced treatment with strong synergistic effect that was at least as robust in reducing ischemic damage as caffeinol. This NMDA receptor antagonist and caffeine combination demonstrated a long window of opportunity, activity in spontaneously hypertensive rats, and, unlike caffeinol, was fully effective in animals chronically pretreated with ethanol. CONCLUSIONS: Our study suggests that antiexcitotoxic properties may underlie some of the anti-ischemic effect of caffeinol. This study provides strong evidence that the anti-ischemic effect of NMDA receptor blockers in general can be dramatically augmented by caffeine, thus opening a possibility for new use of NMDA-based pharmacology in the treatment of stroke. less...
GeneDiseaseDrugProcessesCategories
  • NMDZ1_HUMAN
  • Stroke
  • Caffeine
  • Ethanol
  • Magnesium Sulfate
  • Protein/Gene relationships
  • Drug based Studies
Anti-Ischemic Effect of N-Methyl-D-Aspartate Receptor Blockade Is Potentiated by Caffeine.
GeneDiseaseDrugProcessesCategories
  • NMDZ1_HUMAN
  • Caffeine
  • Protein/Gene relationships
BACKGROUND AND PURPOSE: Although caffeinol (a combination of a low dose of caffeine and ethanol) was shown to robustly reduce stroke damage in experimental models and is now in clinical evaluation for treatment of ischemic stroke, little is known about the potential mechanism of its action.
GeneDiseaseDrugProcessesCategories
  • Stroke
  • Caffeine
  • Ethanol
  • Drug based Studies
RESULTS: Caffeinol reduced the size of excitotoxic lesion, and substitution of ethanol in caffeinol with the NMDA antagonists CNS-1102 and MK-801 but not with MgSO4 produced treatment with strong synergistic effect that was at least as robust in reducing ischemic damage as caffeinol.
GeneDiseaseDrugProcessesCategories
  • Ethanol
  • Magnesium Sulfate
  • Drug based Studies
This NMDA receptor antagonist and caffeine combination demonstrated a long window of opportunity, activity in spontaneously hypertensive rats, and, unlike caffeinol, was fully effective in animals chronically pretreated with ethanol.
GeneDiseaseDrugProcessesCategories
  • Caffeine
  • Ethanol
  • Drug based Studies
This study provides strong evidence that the anti-ischemic effect of NMDA receptor blockers in general can be dramatically augmented by caffeine, thus opening a possibility for new use of NMDA-based pharmacology in the treatment of stroke.
GeneDiseaseDrugProcessesCategories
  • Stroke
  • Caffeine
  • Drug based Studies

Quantification of theobromine and caffeine in saliva, plasma and urine via liquid chromatography-tandem mass spectrometry: A single analytical protocol applicable to cocoa intervention studies.
PMID:20045386
Author: Ptolemy AS, Tzioumis E, Thomke A, Rifai S, Kellogg M
Journal: J Chromatogr B Analyt Technol Biomed Life Sci
Affiliation: Department of Laboratory Medicine, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA.
Targeted analyses of clinically relevant metabolites in human biofluids often require extensive sample preparation (e.g., desalting, protein removal and/or preconcentration) prior to quantitation. In this report, a single ultra-centrifugation based sample pretreatment combined with a designed liquid chromatography-tandem mass spectrometry (LC-MS/MS) protocol provides selective quantification of 3,7-dimethylxanthine (theobromine) and 1,3,7-trimethylxanthine (caffeine) in human saliva, plasma and urine samples. more...
Targeted analyses of clinically relevant metabolites in human biofluids often require extensive sample preparation (e.g., desalting, protein removal and/or preconcentration) prior to quantitation. In this report, a single ultra-centrifugation based sample pretreatment combined with a designed liquid chromatography-tandem mass spectrometry (LC-MS/MS) protocol provides selective quantification of 3,7-dimethylxanthine (theobromine) and 1,3,7-trimethylxanthine (caffeine) in human saliva, plasma and urine samples. The optimized chromatography permitted elution of both analytes within 1.3min of the applied gradient. Positive-mode electrospray ionization and a triple quadruple MS/MS instrument operated in multiple reaction mode were used for detection. (13)C(3) isotopically labeled caffeine was included as an internal standard to improve accuracy and precision. Implementing a 20-fold dilution of the isolated low MW biofluid fraction prior to injection effectively minimized the deleterious contributions of all three matrices to quantitation. The assay was linear over a 160-fold concentration range from 2.5 to 400mumolL(-1) for both theobromine (average R(2) 0.9968) and caffeine (average R(2) 0.9997) respectively. Analyte peak area variations for 2.5mumolL(-1) caffeine and theobromine in saliva, plasma and urine ranged from 5 and 10% (intra-day, N=10) to 9 and 13% (inter-day, N=25) respectively. The intra- and inter-day precision of theobromine and caffeine elution times were 3 and <1% for all biofluids and concentrations tested. Recoveries for caffeine and theobromine ranged from 114 to 118% and 99 to 105% at concentration levels of 10 and 300mumolL(-1). This validated protocol also permitted the relative saliva, plasma and urine distribution of both theobromine and caffeine to be quantified following a cocoa intervention. less...
GeneDiseaseDrugProcessesCategories
  • Caffeine
  • Theophylline
  • Drug based Studies
In this report, a single ultra-centrifugation based sample pretreatment combined with a designed liquid chromatography-tandem mass spectrometry (LC-MS/MS) protocol provides selective quantification of 3,7-dimethylxanthine (theobromine) and 1,3,7-trimethylxanthine (caffeine) in human saliva, plasma and urine samples.
GeneDiseaseDrugProcessesCategories
  • Caffeine
  • Theophylline
  • Drug based Studies
This validated protocol also permitted the relative saliva, plasma and urine distribution of both theobromine and caffeine to be quantified following a cocoa intervention.
GeneDiseaseDrugProcessesCategories
  • Caffeine
  • Drug based Studies

Extracellular production of riboflavin-binding protein, a potential bitter inhibitor, by Brevibacillus choshinensis.
PMID:20045733
Author: Maehashi K, Matano M, Saito M, Udaka S
Journal: Protein Expr Purif
Affiliation: Department of Fermentation Science, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo 156-8502, Japan.
Riboflavin-binding protein (RBP) is a glycophosphoprotein found in hen eggs. We previously identified the extraordinary characteristic of RBP in reducing bitterness. more...
Riboflavin-binding protein (RBP) is a glycophosphoprotein found in hen eggs. We previously identified the extraordinary characteristic of RBP in reducing bitterness. For a more detailed study on the mode of action and industrial application of this characteristic, we investigated the microbial production of recombinant RBP (rRBP). We constructed a chicken RBP gene expression vector by inserting the RBP cDNA in pNCMO2, the Escherichia coli-Brevibacillus choshinensis shuttle vector. B. choshinensis HPD31 transformants produced 0.8 g/l of processed and unglycosylated RBP in a soluble form in the culture supernatant. However, the expressed RBP was partially dimerized and monomeric RBP was purified by two step anion-exchange and gel-filtration chromatographies. The purified rRBP elicited bitterness reduction against quinine and caffeine, although it largely lost its riboflavin-binding ability. These results indicated that glycosylation and riboflavin-binding ability are not essential for the bitterness reduction of RBP. In addition, we assessed the usefulness of the Brevibacillus system for the expression and secretion of RBP as a new type of bitterness inhibitor. less...
GeneDiseaseDrugProcessesCategories
  • Vitamin B2 (Riboflavin)
  • Caffeine
  • Quinine
  • gene expression